Yang Xie

2.5k total citations
45 papers, 1.3k citations indexed

About

Yang Xie is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Yang Xie has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Oncology and 9 papers in Pharmacology. Recurrent topics in Yang Xie's work include Drug Transport and Resistance Mechanisms (10 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Liver Disease Diagnosis and Treatment (4 papers). Yang Xie is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Liver Disease Diagnosis and Treatment (4 papers). Yang Xie collaborates with scholars based in China, United States and Germany. Yang Xie's co-authors include Julie A. Ross, Leslie L. Robison, Stella M. Davies, Ying Xiang, Wen Xie, Haiping Hao, Xuefang Cheng, Guangji Wang, Lijuan Cao and Joseph D. Growney and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Yang Xie

42 papers receiving 1.3k citations

Peers

Yang Xie

ONCOL

PHEOH

SURGE

EPIDE

Elaina Collie–Duguid United Kingdom

Huiyun Wu United States

Lisa Fosdick United States

Hülya Yılmaz Türkiye

Soundararajan Krishnaswamy United States

Cathee Till United States

Barry Hoffman Canada

Touhami Mahjoub Tunisia

Heidrun Karlic Austria

Elaina Collie–Duguid United Kingdom

Yang Xie

956 ×1.6

655 ×1.6

ONCOL

424 ×2.0

PHEOH

208 ×1.3

SURGE

144 ×1.0

EPIDE

Citations per year, relative to Yang Xie Yang Xie (= 1×) peers Elaina Collie–Duguid

Countries citing papers authored by Yang Xie

Since Specialization

Citations

This map shows the geographic impact of Yang Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Xie more than expected).

Fields of papers citing papers by Yang Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Xie. The network helps show where Yang Xie may publish in the future.

Co-authorship network of co-authors of Yang Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Xie. A scholar is included among the top collaborators of Yang Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Xie. Yang Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Ying, et al.. (2025). When simulations meet reality: a critical analysis of conformational accuracy in DNA aptamer-target interactions. Microchemical Journal. 218. 115414–115414.

Li, Xiaoqun, Jia Jia, Minchao Liu, et al.. (2024). Phenylboronic-tannin nanocolloids that scavenge subchondral reactive oxygen microenvironment and inhibit RANKL induced osteoclastogenesis for osteoarthritis treatment. Nano Research. 17(11). 9898–9907. 4 indexed citations

Wang, Laura, Ruichen Rong, Andrew J. Park, et al.. (2024). Assessing disease severity in cutaneous lupus patients using natural language processing: Preliminary data from a cohort study. Journal of the American Academy of Dermatology. 92(4). 894–896. 1 indexed citations

Cai, Ling, Ralph J. DeBerardinis, Xiaowei Zhan, Guanghua Xiao, & Yang Xie. (2024). Navigating electronic health record accuracy by examination of sex incongruent conditions. Journal of the American Medical Informatics Association. 31(12). 2849–2856. 6 indexed citations

Liu, Bixia, Yang Xie, Jiayu Zhang, et al.. (2024). SERPINB5 promotes colorectal cancer invasion and migration by promoting EMT and angiogenesis via the TNF-α/NF-κB pathway. International Immunopharmacology. 131. 111759–111759. 17 indexed citations

Tardelli, Matteo, Kristal Maner-Smith, Thomas J. Bowen, et al.. (2023). Ligand dependent interaction between PC-TP and PPARδ mitigates diet-induced hepatic steatosis in male mice. Nature Communications. 14(1). 2748–2748. 8 indexed citations

Xu, Pengfei, Yue Xi, Junjie Zhu, et al.. (2021). Intestinal Sulfation Is Essential to Protect Against Colitis and Colonic Carcinogenesis. Gastroenterology. 161(1). 271–286.e11. 42 indexed citations

Xie, Yang, et al.. (2021). Effects of chronic HBV infection on lipid metabolism in non-alcoholic fatty liver disease: A lipidomic analysis. Annals of Hepatology. 24. 100316–100316. 15 indexed citations

Zhou, Dong, Yang Xie, You‐Jin Choi, et al.. (2020). Inhibition of Estrogen Sulfotransferase (SULT1E1/EST) Ameliorates Ischemic Acute Kidney Injury in Mice. Journal of the American Society of Nephrology. 31(7). 1496–1508. 16 indexed citations

10.

Xie, Yang, Meishu Xu, Songrong Ren, et al.. (2019). Hepatic Estrogen Sulfotransferase Distantly Sensitizes Mice to Hemorrhagic Shock-Induced Acute Lung Injury. Endocrinology. 161(1). 5 indexed citations

11.

Wang, Pengcheng, Pengfei Xu, Yang Xie, et al.. (2019). An Unexpected Role of Cholesterol Sulfotransferase and its Regulation in Sensitizing Mice to Acetaminophen-Induced Liver Injury. Molecular Pharmacology. 95(6). 597–605. 8 indexed citations

12.

Zhang, Yumei, et al.. (2017). Serum pharmacokinetics and coagulation aberration induced by sodium dehydroacetate in male and female Wistar rats. Scientific Reports. 7(1). 46210–46210. 17 indexed citations

13.

Xie, Yang, Hong Wang, Xuefang Cheng, et al.. (2016). Farnesoid X receptor activation promotes cell proliferation via PDK4-controlled metabolic reprogramming. Scientific Reports. 6(1). 18751–18751. 29 indexed citations

14.

Wang, Hong, Tingting Yan, Yuan Xie, et al.. (2015). Mechanism-Based Inhibitory and Peroxisome Proliferator-Activated Receptor α–Dependent Modulating Effects of Silybin on Principal Hepatic Drug-Metabolizing Enzymes. Drug Metabolism and Disposition. 43(4). 444–454. 20 indexed citations

15.

Xie, Yang, et al.. (2014). [Progress in the role of farnesoid X receptor in metabolic regulation and tumor cell proliferation].. PubMed. 66(2). 252–8. 1 indexed citations

16.

Zhou, Xueyan, Yang Xie, Qi Qu, et al.. (2012). Disturbance of Hepatic and Intestinal UDP-glucuronosyltransferase in Rats with Trinitrobenzene Sulfonic Acid-induced Colitis. Drug Metabolism and Pharmacokinetics. 28(4). 305–313. 19 indexed citations

17.

Tao, Weike, et al.. (2012). Incidence of unanticipated difficult airway in obstetric patients in a teaching institution. Journal of Anesthesia. 26(3). 339–345. 19 indexed citations

18.

Blair, Cindy K., Michelle A. Roesler, Yang Xie, et al.. (2008). Vitamin supplement use among children with Down's syndrome and risk of leukaemia: a Children's Oncology Group (COG) study. Paediatric and Perinatal Epidemiology. 22(3). 288–295. 9 indexed citations

19.

Xie, Yang, Stella M. Davies, Ying Xiang, Leslie L. Robison, & Julie A. Ross. (2003). Trends in leukemia incidence and survival in the United States (1973–1998). Cancer. 97(9). 2229–2235. 180 indexed citations

20.

Ross, Julie A., Yang Xie, Stella M. Davies, et al.. (2003). Prescription medication use during pregnancy and risk of infant leukemia (United States). Cancer Causes & Control. 14(5). 447–451. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact